After slowing down in the final weeks of 2021, IPO activity has picked up momentum despite the uncertain economic conditions. Eye care
IPO Alert: Here’s all you need to know about Bausch + Lomb’s market debut
After slowing down in the final weeks of 2021, IPO activity has picked up momentum despite the uncertain economic conditions. Eye care
UnitedHealth Group Incorporated (NYSE: UNH) Q4 2021 earnings call dated Jan. 19, 2022 Corporate Participants: Sir Andrew Witty — Chief Executive Officer Dirk McMahon — President
Tilray (NASDAQ: TLRY) reported second-quarter 2022 financial results before the regular market hours on Monday. Total net revenue increased 20% year-over-year to
Angiodynamics Inc (NASDAQ: ANGO) Q2 2022 earnings call dated Jan. 06, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer
Rite Aid Corporation (NYSE: RAD) Q3 2022 earnings call dated Dec. 21, 2021 Corporate Participants: Trent Kruse -- Senior Vice President of Investor Relations
After record activity, the IPO market has entered a lull phase as the year comes to a close. Unlike in the past,
HEXO Corp. (NYSE: HEXO) Q1 2022 earnings call dated Dec. 14, 2021 Corporate Participants: Jennifer Smith — Director, Investor Relations Scott Cooper — President, Chief Executive Officer
HEXO Corp. (NYSE: HEXO) Q1 2022 earnings call dated Dec. 14, 2021 Corporate Participants: Jennifer Smith -- Director, Investor Relations Scott Cooper -- President, Chief Executive
Champions Oncology, Inc. (NASDAQ: CSBR) Q2 2022 earnings call dated Dec. 13, 2021. Corporate Participants: Ronnie Morris -- President & Chief Executive Officer David
Avid Bioservices, Inc. (NASDAQ: CDMO) Q2 2022 earnings call dated Dec. 07, 2021 Corporate Participants: Tim Brons -- Investor Relations, Vida Strategic Partners Nicholas
Medtronic PLC (NYSE: MDT) Q2 2022 earnings call dated Nov. 23, 2021 Corporate Participants: Ryan Weispfenning -- Vice President and Head - Investor Relations
Agilent Technologies Inc. (NYSE: A) Q4 2021 earnings call dated Nov. 22, 2021 Corporate Participants: Parmeet Ahuja -- Vice President, Investor Relations Mike McMullen -- President
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) Q4 2021 earnings call, dated Nov. 22, 2021. Corporate Participants: Vince Anzalone -- Vice President of Investor Relations Christopher
Colgate-Palmolive Company (NYSE: CL) reported its third-quarter financial results for the period ended September 30, 2021. GAAP net income for the third
DELTA 9 CANNABIS INC (TSX : DN) Q3 2021 earnings call dated Nov. 15, 2021. Corporate Participants: Alexa Goertzen -- Manager of Corporate Affairs
Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2021 earnings call dated Nov. 08, 2021 Corporate Participants: Will Gramig -- Senior Analyst Derek Chalmers -- Chief Executive Officer,
Becton, Dickinson and Company (NYSE: BDX) Q4 2021 earnings call dated Nov. 04, 2021 Corporate Participants: Nadia Goncalves -- Senior Director, Investor Relations Tom
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
CVS Health Corporation (NYSE: CVS) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Susie Lisa -- Senior Vice President of Investor Relations
Pfizer Inc (NYSE:PFE) Q3 2021 earnings call dated Nov. 02, 2021. Corporate Participants: Chris Stevo -- Senior Vice President and Chief Investment Relations Officer
McKesson Corporation (NYSE: MCK) Q2 2022 earnings call dated Nov. 01, 2021 Corporate Participants: Rachel Rodriguez -- Investor Relations Brian S. Tyler -- Chief Executive Officer